CHICAGO and PARK CITY, UT – January 5, 2025 – Content Carnivores, a leading healthcare communications firm, is proud to announce its 18th consecutive year participating in the JP Morgan Healthcare Conference and Biotech Showcase in San Francisco. These concurrent events, taking place this January, represent the largest gathering of healthcare, biotech, medtech, diagnostic, and pharmaceutical companies worldwide.
Industry Veterans Leading the Charge:
Founder Jeffrey Walker and VP of Customer Success/Partner Chelli Miller will be representing Content Carnivores, leveraging their extensive experience to support clients who are presenting at the conference and each moderating non-client company presentations at Biotech Showcase. Their presence further signifies Content Carnivores' commitment to driving thought leadership within the healthcare industry.
Clients Taking Center Stage:
Content Carnivores is proud to support several clients who will be present at the conferences during JPM Week, including:
- BioUtah: The leading trade association for the life sciences industry in Utah. BioUtah will participate in hosting a Multi-State Reception on Sunday night, kicking off the week with networking opportunities alongside other state bioscience associations. This event marks BioUtah's first year sponsoring a reception during JPM Week, demonstrating its commitment to the global life sciences community and the industry's growth in Utah. BioUtah CEO Kelvyn Cullimore will be on hand to discuss and promote the state's business-friendly environment and growing life sciences ecosystem.
- Colliers International: A global leader in commercial real estate with a growing focus on life sciences in Salt Lake City. Colliers will highlight the region's burgeoning life sciences sector and its expanding need for specialized lab space, headquarters, and other facilities. Managing Partner Chris Kirk will represent the company and their expanded focus on science and technology companies.
- GeoVax Labs: A clinical-stage biotechnology company developing next-generation vaccines for infectious diseases and cancer. GeoVax will present at Biotech Showcase, highlighting their recent $400 million BARDA grant for a 10,000-patient trial and, separately, updates on their progress with their head and neck cancer therapy.
- Geovax CEO David Dodd will present at Biotech Showcase on January 14, 2025, at 10:30 am PST at the Hilton Union Square, 333 O’Farrell Street, Yosemite A (Ballroom Level).
- Pacylex Therapeutics: This exciting company, with its first-in-class therapy, zelenirstat, presents a compelling investment opportunity in the oncology space. Zelenirstat targets a novel pathway, potentially surpassing existing treatments in efficacy and tolerability. Pacylex CEO Michael Weickert is raising a Series B financing and is available to connect through the BIO partnering system.
In addition to client support, Content Carnivores will also be moderating company presentations at the prestigious Biotech Showcase for the 7th year, introducing emerging and established companies to a global audience.
"We are thrilled to be celebrating our 18th anniversary at these pivotal healthcare events," says Chelli Miller, VP at Content Carnivores. "This year is particularly exciting as we support our clients in making significant strides in their respective fields and contribute to the advancement of the global life sciences industry."
Connect with Content Carnivores at JPM:
The J.P. Morgan Healthcare Conference provides a primetime opportunity to connect with investors, partners, and industry leaders. We look forward to fostering collaboration and driving success for their clients at this dynamic moment in healthcare. To learn more about Content Carnivores and their clients at the J.P. Morgan Healthcare Conference, please contact:
Chelli@ContentCarnivores.com
The company founders have run innovative content marketing and advertising programs for global marketing pioneers. Current clients include leaders in healthcare, marketing, medical devices, financial services, and technology.
